The paper is concerned with acute pyelonephritis pathogenesis in patients with a solitary kidney. Upon nephrectomy, the remaining kidney undergoes compensatory-adaptive processes giving rise to injury of the first barrier of the local nonspecific resistance. This results in more rapid and severe course of acute pyelonephritis, development of pyodestructive disease, protracted run. Active surgical policy in acute obturation pyelonephritis in patients with a single kidney, early recovery of adequate urine outflow can prevent progression to destructive pyelonephritis and advance treatment results.

Download full-text PDF

Source

Publication Analysis

Top Keywords

remaining kidney
8
acute pyelonephritis
8
[the characteristics
4
acute
4
characteristics acute
4
acute infectious-inflammatory
4
infectious-inflammatory process
4
process single
4
single remaining
4
kidney
4

Similar Publications

Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors.

JAMA Intern Med

January 2025

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Importance: Evidence on cardiovascular benefits and safety of sodium-glucose cotransporter 2 (SGLT-2) inhibitors is mainly from placebo-controlled trials. Therefore, the comparative effectiveness and safety of individual SGLT-2 inhibitors remain unknown.

Objective: To compare the use of canagliflozin or dapagliflozin with empagliflozin for a composite outcome (myocardial infarction [MI] or stroke), heart failure hospitalization, MI, stroke, all-cause death, and safety outcomes, including diabetic ketoacidosis (DKA), lower-limb amputation, bone fracture, severe urinary tract infection (UTI), and genital infection and whether effects differed by dosage or cardiovascular disease (CVD) history.

View Article and Find Full Text PDF

Objectives: To report the feasibility of a fluid management practice bundle and describe the pre- vs. post-implementation prevalence and odds of cumulative fluid balance greater than 10% in critically ill pediatric patients with respiratory failure.

Design: Retrospective cohort from May 2022 to December 2022.

View Article and Find Full Text PDF

Deciphering the most promising strategy for the evolution of cancer patient management remains a multifaceted, challenging affair to date. Additionally, such approaches often lead to microbial infections as side effects, probably due to the compromised immunity of the patients undergoing such treatment. Distinctly, this work delineates a rational combinatorial strategy harnessing stereogenic harmony in the diphenylalanine fragment, tethering it to an amphiphile 12-hydroxy-lauric acid at the N-terminus (compounds -) such that a potential therapeutic could be extracted out from the series.

View Article and Find Full Text PDF

Introduction: Phosphate (P) binders are among the most common medications prescribed to control P levels in patients with chronic kidney disease on dialysis. There is still a paucity of data on adherence to P binders with no comparison between dialysis modalities.

Methods: We accessed factors associated with P binder adherence among patients on dialysis in an academic hospital.

View Article and Find Full Text PDF

The impact of different exercise modalities on chronic kidney disease: an umbrella review of meta-analyses.

Front Physiol

January 2025

Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States.

Introduction: Exercise is widely recognized for its benefits to chronic kidney disease (CKD) patients. However, the specific impact of different exercise modalities on CKD-related outcomes remains unclear. This study sought to summarize the effects of different exercise modalities on the main outcomes impacted by CKD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!